Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofbromatosis and a Factor V Leiden Mutation

Journal Title: Sultan Qaboos University Medical Journal - Year 2017, Vol 17, Issue 4

Abstract

Type I neurofbromatosis is characterised by altered skin pigmentation and the growth of benign tumours, particularly along the peripheral nerves and central nervous system. We report a 36-year-old primigravida woman in labour who was admitted to the obstetric suite of the Hospital Sant Joan de Déu, Barcelona, Spain, in 2007 with hypothyroidism, type I neurofbromatosis and a factor V Leiden mutation. Due to a lack of cranial and spinal imaging data, an epidural was not indicated; instead, continuous intravenous remifentanil analgaesia was administered. Te remifentanil infusion was self-titrated by the patient using a visual analogue scale, with the dosage ranging from 0.01 to 0.25 μg/kg/minute. Due to rotational dystocia, Kjelland-type forceps were used during the delivery. After birth, the infant was found to have Apgar scores of 9 and 10, with no maternal or neonatal adverse effects observed. Although still controversial, remifentanil may be a successful alternative for analgaesia in similar cases; however, the specifc risks and benefts for each patient should be considered prior to administration.

Authors and Affiliations

José L. Gálvez| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, Carlos L. Errando| Departments of Surgical Services and Anaesthesiology, Resuscitation & Pain Therapeutics, Consorcio Hospital General Universitario de Valencia, Valencia, Spain, Silvia Serrano| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital Sant Joan de Déu, Barcelona, Spain, Marga Martín-Ayuso| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, José M. Valverde-Mantecón| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Keywords

Related Articles

Decision-to-Delivery Time Intervals in Emergency Caesarean Section Cases Repeated cross-sectional study from Oman

Objectives: In cases of fetal intolerance to labour, meeting the standard decision-to-delivery time interval (DDI) of ≤30 minutes is challenging. Tis study aimed to assess DDIs in emergency Caesarean section (CS) cas...

Supraventricular tachycardia in children: a report of three cases, diagnosis and current management

The article presents three Omani children with supraventricular tachycardia and discusses the diagnosis and management. Clinical features along with ECG help diagnosis of this common paediatric arrhythmia. Acute managem...

Soft Tissue Rosai-Dorfman Disease Case report

Rosai-Dorfman disease (RDD) is a rare benign proliferative histiocytic disorder characterised by massive lymphadenopathy. While extranodal involvement can occur in generalised RDD, isolated soft tissue RDD (STRDD) is e...

Recurrent Dermatofibrosarcoma Protuberans with Pigmentation and Myoid Differentiation

Dermatofibrosarcomas protuberans (DFSP) are rare low-grade tumours with various subtypes and usually occur among middle-aged adults. However, myoid differentiation is very rare. We report a 44-year-old woman who presente...

Patients’ and Nurses’ Perceptions of Post-Coronary Artery Bypass Graft Learning Needs in Two Omani Hospitals

ABSTRACT: Objectives: Little is known about nurses’ and patients’ perceptions of learning needs following coronary artery bypass graft (CABG) surgery in Oman. This study aimed to identify patients' and nurses' perception...

Download PDF file
  • EP ID EP14827
  • DOI 10.18295/squmj.2017.17.04.016
  • Views 338
  • Downloads 17

How To Cite

José L. Gálvez, Carlos L. Errando, Silvia Serrano, Marga Martín-Ayuso, José M. Valverde-Mantecón (2017). Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofbromatosis and a Factor V Leiden Mutation. Sultan Qaboos University Medical Journal, 17(4), 468-471. https://europub.co.uk/articles/-A-14827